Related Experiment Video

Updated: May 7, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression

Xiao-Lei Li1, Lan-Ling Jia, Mu-Mu Shi

  • 1Department of Pathology, the First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, Shenyang 110001, China. xinshanjia@126.com.

Journal of Translational Medicine
|September 28, 2013
PubMed
Abstract

Insights

Oct4 and KPNA2 are crucial for non-small-cell lung cancer (NSCLC) progression. Their interaction facilitates Oct4 nuclear entry, impacting cancer cell proliferation and survival.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Oct4 is a key transcription factor regulating stem cell self-renewal and differentiation.
  • Nuclear entry and retention of Oct4 are essential for its transcriptional functions.
  • KPNA2, a karyopherin family member, is vital for nucleocytoplasmic transport.

Purpose of the Study:

  • To investigate the association between Oct4 and KPNA2 expression levels.
  • To correlate these expression levels with clinicopathological characteristics and prognosis in non-small-cell lung cancer (NSCLC).

Main Methods:

  • Immunohistochemistry to assess Oct4 and KPNA2 expression in NSCLC tissues.
  • Real-time PCR and Western blotting for mRNA and protein analysis in cell lines.
  • siRNA-mediated knockdown, immunofluorescence, and co-immunoprecipitation to study interactions and functional effects.

Main Results:

  • Oct4 and KPNA2 were overexpressed in NSCLC tissues and correlated with clinicopathological features.
  • Higher Oct4 and KPNA2 expression was associated with poorer overall survival.
  • KPNA2 knockdown reduced Oct4 mRNA and nuclear levels, inhibiting NSCLC cell proliferation.
  • Co-immunoprecipitation confirmed an interaction between Oct4 and KPNA2.

Conclusions:

  • Oct4 and KPNA2 play significant roles in NSCLC progression.
  • KPNA2 mediates Oct4 nuclear localization, suggesting a potential therapeutic target.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.